Invitation to the presentation of ALK’s first quarter 2025 results on Tuesday, 6 May 2025

Group 1 - ALK will publish its Q1 2025 results on May 6, 2025, and will host an investor presentation at 11:00 a.m. CEST the same day [1] - The presentation will be available for live audio webcast and replay on ALK's website [2] - Participants can register for the conference call via a provided link and will receive dial-in details via email [3] Group 2 - ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma, headquartered in Hørsholm, Denmark, employing around 2,800 people [6]